, Global Tuberculosis Report. Geneva. World Health Organization, 2019.

M. Vukmanovic-stejic, J. R. Reed, K. E. Lacy, M. H. Rustin, and A. N. Akbar, Mantoux Test as a model for a secondary immune response in humans, Immunol. Lett, vol.107, pp.93-101, 2006.

D. Shingadia and V. Novelli, The tuberculin skin test: a hundred, not out?, Arch. Dis. Child, vol.93, pp.189-190, 2008.

R. Diel, Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis, Eur. Respir. J, vol.37, pp.88-99, 2011.

D. Goletti, A. Sanduzzi, and G. Delogu, Performance of the Tuberculin Skin Test and Interferon-? Release Assays: An Update on the Accuracy, Cutoff Stratification, and New Potential Immune-based Approaches, The Journal of Rheumatology Supplement, vol.91, pp.24-31, 2014.

E. N. Ndzi, The pros and cons of the QuantiFERON test for the diagnosis of tuberculosis, prediction of disease progression, and treatment monitoring, Int J Mycobacteriol, vol.5, pp.177-184, 2016.

A. O'garra, The immune response in tuberculosis, Annu. Rev. Immunol, vol.31, pp.475-527, 2013.

T. R. Rustad, A. M. Sherrid, K. J. Minch, and D. R. Sherman, Hypoxia: a window into Mycobacterium tuberculosis latency, Cell. Microbiol, vol.11, pp.1151-1159, 2009.

R. L. Leistikow, The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy, J. Bacteriol, vol.192, pp.1662-1670, 2010.

S. D. Schuck, Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection, PLoS ONE, vol.4, p.5590, 2009.

J. R. Landis and G. G. Koch, The Measurement of Observer Agreement for Categorical. Data, Biometrics, vol.33, p.159, 1977.

D. Peña, A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérinvaccinated Individuals, vol.2, pp.884-890, 2015.

J. M. Grange and A. Zumla, The global emergency of tuberculosis: what is the cause?, J R Soc Promot Health, vol.122, pp.78-81, 2002.

T. M. Perez-porcuna, Prevalence and Diagnosis of Latent Tuberculosis Infection in Young Children in the Absence of a Gold Standard, plos one, vol.11, p.164181, 2016.

S. Singh, M. Sharma, A. Chaudhry, and S. Sharma, Rv2626c and Rv2032 activate TH1 response and downregulate regulatory T cells in peripheral blood mononuclear cells of tuberculosis patients, Comp. Immunol. Microbiol. Infect. Dis, vol.62, pp.46-53, 2019.

M. Prabhavathi, B. Pathakumari, and A. Raja, IFN-?/TNF-? ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis -The most suitable surrogate biomarker for latent TB infection, J. Infect, vol.71, pp.238-249, 2015.

D. Goletti, Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection, Eur. Respir. J, vol.36, pp.135-142, 2010.

I. Rosenkrands, Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins, J. Bacteriol, vol.184, pp.3485-3491, 2002.

S. Ashraf, Evaluation of diagnostic potential of Rv3803c and Rv2626c recombinant antigens in TB endemic country Pakistan, J Immunoassay Immunochem, vol.35, pp.120-129, 2014.

F. Abebe and G. Bjune, The protective role of antibody responses during Mycobacterium tuberculosis infection, Clin. Exp. Immunol, vol.157, pp.235-243, 2009.

L. Kozakiewicz, J. Phuah, J. Flynn, and J. Chan, The role of B cells and humoral immunity in Mycobacterium tuberculosis infection, Adv. Exp. Med. Biol, vol.783, pp.225-250, 2013.

M. Coppola, Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression, Tuberculosis, vol.106, pp.25-32, 2017.

L. S. De-araujo, IgG subclasses' response to a set of mycobacterial antigens in different stages of Mycobacterium tuberculosis infection, Tuberculosis (Edinb), vol.108, pp.70-76, 2018.

S. T. Hoff, Evaluation of Mycobacterium tuberculosis-specific antibody responses in populations with different levels of exposure from Tanzania, Clin. Infect. Dis, vol.45, pp.575-582, 2007.

R. Baumann, Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets, J. Infect, vol.69, pp.581-589, 2014.

A. Azzurri, Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea, Int J Immunopathol Pharmacol, vol.19, pp.199-208, 2006.

A. Davidow, Antibody profiles characteristic of Mycobacterium tuberculosis infection state, Infect. Immun, vol.73, pp.6846-6851, 2005.

N. R. Pollock, Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?, Infect Control Hosp Epidemiol, vol.29, pp.878-886, 2008.

J. S. Park, Monthly follow-ups of interferon-? release assays among health-care workers in contact with patients with TB, Chest, vol.142, pp.1461-1468, 2012.

E. V. Zerbini, Programa Nacional de Control de la Tuberculosis: Normas Técnicas. Insituto Nacional de Enfermedades Respiratorias Dr, 2013.